Literature DB >> 19318437

Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.

Zoe R Edelstein1, Margaret M Madeleine, James P Hughes, Lisa G Johnson, Stephen M Schwartz, Denise A Galloway, Joseph J Carter, Laura A Koutsky.   

Abstract

BACKGROUND: Given the established links among young age at first intercourse (AFI), number of sex partners, high-risk human papillomavirus infection, and squamous cell cervical cancer (SCC), we hypothesized that women diagnosed with SCC at younger ages would be more likely to report young AFI than women diagnosed later in life.
METHODS: We performed a population-based investigation among invasive SCC cases who were diagnosed between 1986 and 2004, were ages 22 to 53 years, and lived in the metropolitan Seattle-Puget Sound region (n = 333). Using multivariate linear regression, we estimated coefficients and 95% confidence intervals (95% CI) to assess the association between age at SCC diagnosis and AFI (<15, 15-18, > or =19 years) and number of sex partners at age <20 years (0, 1, 2-4, 5-14, > or =15), accounting for birth year and other factors. Interactions were assessed using the likelihood ratio test.
RESULTS: The interval between AFI and SCC diagnosis ranged from 4 to 35 years. In a multivariate model, compared with SCC cases reporting AFI > or =19, the mean age of diagnosis was 3.1 years younger for SCC cases reporting AFI <15 (95% CI, -5.8 to -0.5) and 2.6 years younger for SCC cases reporting AFI 15 to 18 (95% CI, -4.6 to -0.6). Although number of sex partners at age <20 years was associated with age at SCC diagnosis in a crude analysis, the association was not independent of AFI. However, in the AFI > or =19 and <15 groups, differences in effect were seen by number of sex partners at age <20 years (P(interaction) = 0.08), with the association remaining strong and significant only in the AFI <15 group that had > or =2 partners at age <20 years (coefficient, -4.2; 95% CI, -6.3 to -2.1).
CONCLUSION: Among younger and middle-aged women with SCC, early age of diagnosis was associated with early AFI, although the effect appeared to be modified by number of sex partners at age <20 years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318437      PMCID: PMC2667560          DOI: 10.1158/1055-9965.EPI-08-0707

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

Review 1.  Natural history of cervical neoplasia: defining progression and its consequence.

Authors:  A P Pinto; C P Crum
Journal:  Clin Obstet Gynecol       Date:  2000-06       Impact factor: 2.190

Review 2.  The effect of cancer treatment on female fertility and strategies for preserving fertility.

Authors:  Theodoros Maltaris; Rudolf Seufert; Franz Fischl; Michael Schaffrath; Kunhard Pollow; Heinz Koelbl; Ralf Dittrich
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-09-15       Impact factor: 2.435

3.  Politics, parents, and prophylaxis--mandating HPV vaccination in the United States.

Authors:  R Alta Charo
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

4.  Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.

Authors:  Long Fu Xi; Nancy B Kiviat; Allan Hildesheim; Denise A Galloway; Cosette M Wheeler; Jesse Ho; Laura A Koutsky
Journal:  J Natl Cancer Inst       Date:  2006-08-02       Impact factor: 13.506

5.  Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.

Authors: 
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

Review 6.  Chapter 6: Epidemiology and transmission dynamics of genital HPV infection.

Authors:  Ann N Burchell; Rachel L Winer; Silvia de Sanjosé; Eduardo L Franco
Journal:  Vaccine       Date:  2006-06-02       Impact factor: 3.641

Review 7.  Chapter 5: Updating the natural history of HPV and anogenital cancer.

Authors:  Anna-Barbara Moscicki; Mark Schiffman; Susanne Kjaer; Luisa L Villa
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

8.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

Review 9.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

10.  Parental attitudes to pre-pubertal HPV vaccination.

Authors:  Laura A V Marlow; Jo Waller; Jane Wardle
Journal:  Vaccine       Date:  2007-01-22       Impact factor: 3.641

View more
  5 in total

1.  Time since first sexual intercourse and the risk of cervical cancer.

Authors:  Martyn Plummer; Julian Peto; Silvia Franceschi
Journal:  Int J Cancer       Date:  2011-08-12       Impact factor: 7.396

2.  A study of association between cervical cytology and period of co-habitation with husbands in the wives of serving soldiers.

Authors:  Parikshit Sanyal; R Kunwar; P J Borpujari; Sanghita Barui
Journal:  Med J Armed Forces India       Date:  2018-07-04

3.  Screening and cervical cancer cure: population based cohort study.

Authors:  Bengt Andrae; Therese M-L Andersson; Paul C Lambert; Levent Kemetli; Lena Silfverdal; Björn Strander; Walter Ryd; Joakim Dillner; Sven Törnberg; Pär Sparén
Journal:  BMJ       Date:  2012-03-01

4.  Errors in recall of age at first sex.

Authors:  Wenbin Liang; Tanya Chikritzhs
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

5.  The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis.

Authors:  Jinyun Li; Chongchang Zhou; Haojie Zhou; Tianlian Bao; Tengjiao Gao; Xiangling Jiang; Meng Ye
Journal:  Ther Clin Risk Manag       Date:  2016-08-18       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.